SLU-PP-332

Overview

SLU-PP-332 is a novel research compound classified as a REV-ERB agonist. It is being investigated in laboratory settings for its potential to modulate circadian rhythm, lipid metabolism, and energy expenditure in preclinical models such as laboratory rodents. SLU-PP-332 acts on the REV-ERB nuclear receptors, which play key roles in regulating the body’s internal clock and metabolic pathways.

Benefits

In preclinical research, SLU-PP-332 has demonstrated the potential to enhance energy expenditure, reduce fat mass, and improve lipid and glucose metabolism in test subjects. Studies suggest REV-ERB agonists like SLU-PP-332 may offer promising insights for research on obesity, metabolic health, and circadian biology.
Source: Griffin P, et al. REV-ERBα activation modulates circadian behavior and metabolism. Nature, 2019.

Possible Side Effects

In laboratory research, test subjects administered SLU-PP-332 have shown minimal adverse effects; however, possible side effects may include mild changes in activity patterns, fluctuations in sleep-wake cycles, or transient metabolic variations, depending on dosage, frequency, and the species studied.
Source: Griffin P, et al., Nature, 2019.

Dosage & Administration

SLU-PP-332 is typically administered via intraperitoneal or subcutaneous injection under approved laboratory protocols. Typical research dosing ranges from 10 mg/kg to 100 mg/kg, depending on the study design, species used, and desired research endpoints. Frequency varies but is often once daily or multiple times per week in metabolic and circadian rhythm studies.
For laboratory research use only. Not for human consumption.

Summary

SLU-PP-332 is an innovative REV-ERB agonist compound designed exclusively for research exploring circadian regulation, lipid metabolism, and energy balance in preclinical models. Studies suggest it may help increase energy expenditure and modulate metabolic pathways, with minimal side effects observed in test subjects. SLU-PP-332 is administered under strict laboratory protocols, with dosage and frequency adjusted according to research goals and species.
Strictly for research purposes only. Not for human use.